Biogen Inc.
BIIB· Nasdaq
BIIBBiogen Inc.
Filed Oct 21, 2009 · 10-Q · 21 days after period end · 0000950123-09-051956
| Metric | Q3 2009 | Q3 2008 |
|---|---|---|
| Revenue | $1.12B | $1.09B |
| Net Income | $277.70M | $206.79M |
| EPS Diluted | $0.95 | $0.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
ended Sep 30, 2009 · filed Oct 21, 2009 · 21 d after period end
